Suppr超能文献

H-4-II-E肿瘤细胞系统的特性。I. 实验性肝癌的生长及细胞增殖动力学

Properties of the H-4-II-E tumor cell system. I. Growth and cell proliferation kinetics of an experimental hepatoma.

作者信息

Evans M J, Kovacs C J

出版信息

Cell Tissue Kinet. 1977 May;10(3):233-43.

PMID:194696
Abstract

Growth and cell proliferation kinetics of hepatoma H-4-II-E and its tissue culture derivative have been studied to establish the characteristics of an in vivo--in vitro solid tumor model. The H-4-II-E line, originating from the Reuber H-35 hepatoma, can be maintained and studied either in cell culture or as a transplantable solid tumor in ACI male rats. In addition it allows for the in vitro assay of cell survival following treatment of animal tumors in situ. In vivo, hepatoma H-4-II-E is rapidly growing tumor with a mean doubling time of 49-2 hr. The cell cyle time is 39-1 hr with a cell loss factor of 0-32. Retrospective examination of tumor specimens obtained during the establishment of the H-4-II-E tumor system demonstrates that both structural as well as cell population changes have occurred. The biological characteristics of the primary tumor (H-35) and an early intermediate stage (H-35tc2) are compared with H-4-II-E and the histopathological, growth and cell kinetic changes are discussed.

摘要

对肝癌H-4-II-E及其组织培养衍生物的生长和细胞增殖动力学进行了研究,以确定一种体内-体外实体瘤模型的特征。源自鲁伯H-35肝癌的H-4-II-E细胞系,可以在细胞培养中维持和研究,也可以作为可移植实体瘤在ACI雄性大鼠体内进行研究。此外,它还允许对原位治疗动物肿瘤后的细胞存活进行体外测定。在体内,肝癌H-4-II-E是一种快速生长的肿瘤,平均倍增时间为49-2小时。细胞周期时间为39-1小时,细胞丢失率为0-32。对在H-4-II-E肿瘤系统建立过程中获得的肿瘤标本进行回顾性检查表明,结构和细胞群体都发生了变化。将原发性肿瘤(H-35)和早期中间阶段(H-35tc2)的生物学特性与H-4-II-E进行比较,并讨论了组织病理学、生长和细胞动力学变化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验